High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations.
about
The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.Genes associated with genotype-specific DNA methylation in squamous cell carcinoma as candidate drug targets.PIK3CA gene mutations in Northwest Chinese esophageal squamous cell carcinomaAnalysis and comparison of somatic mutations in paired primary and recurrent epithelial ovarian cancer samples.PIK3CA gene mutations and overexpression: implications for prognostic biomarker and therapeutic target in Chinese esophageal squamous cell carcinoma.High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutatedAssociations of PI3KR1 and mTOR polymorphisms with esophageal squamous cell carcinoma risk and gene-environment interactions in Eastern Chinese populations.Designing a high-throughput somatic mutation profiling panel specifically for gynaecological cancers.Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma.Preclinical evaluation of afatinib (BIBW2992) in esophageal squamous cell carcinoma (ESCC).Prognostic implications of PIK3CA amplification in curatively resected liposarcomaPIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.KRAS and BRAF mutations in 203 esophageal squamous cell carcinomas: pyrosequencing technology and literature review.High-incidence of PTEN mutations in Chinese patients with primary small cell carcinoma of the esophagusPIK3CA hypomethylation plays a key role in activation of the PI3K/AKT pathway in esophageal cancer in Chinese patients.Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer.Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy.Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma.Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma.Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma.PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue
P2860
Q27853223-F24C4B70-0787-4726-9108-C0470C3E5AC3Q30359391-D9DD5AC0-6F41-451F-8CA9-8F533E6CA8F9Q33572680-0A8A14B3-9769-4FE2-AE02-53ED6DDFC2F8Q33768759-7F592446-C22C-4D4D-9494-DF1BE01278EDQ33940350-10D1A211-4FBC-4F12-B25D-50AF7B4CC03BQ34541232-999C40C9-64F6-423E-9691-3E7FC11B6AABQ35053048-BA42D200-E79F-41E8-AA73-227FCA3DFA9AQ35132338-46B99020-22BA-44F7-A908-C6FA0E64A9DAQ36244592-162DC8CD-774B-49EF-998E-0969B0B4C9E0Q36516577-57491188-EB3E-440F-85EB-EB0A8B56DCE1Q37269360-87C8E28F-21B3-40B9-AAB3-A0E57D3DA0ABQ37327580-424CDBCA-1D7F-46D3-8582-FC921A2ED650Q37369576-CD1023AC-006C-44D4-B379-4054DB7C6A86Q37609759-B2490319-5FA6-418A-AFC8-A6FF715F724FQ37728444-E523ADEA-5795-45E5-82D8-8FD4EFF95445Q40564690-DDD7F3E9-53B3-4289-A5F7-B5E0E837B165Q41867768-E426ED32-489E-4E8B-955E-99C9FC229F5CQ48012424-9E81024C-AD99-4368-84A7-322C0B96BFF9Q52889584-2F9BC13F-8A62-4BBF-9643-52839B7F8E61Q53220241-458156DF-B830-4F5C-B995-E4657042735AQ57168934-4B6A28D2-92B2-4A42-A820-7B0743DBA25C
P2860
High-throughput genotyping in metastatic esophageal squamous cell carcinoma identifies phosphoinositide-3-kinase and BRAF mutations.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
High-throughput genotyping in ...... e-3-kinase and BRAF mutations.
@ast
High-throughput genotyping in ...... e-3-kinase and BRAF mutations.
@en
High-throughput genotyping in ...... e-3-kinase and BRAF mutations.
@nl
type
label
High-throughput genotyping in ...... e-3-kinase and BRAF mutations.
@ast
High-throughput genotyping in ...... e-3-kinase and BRAF mutations.
@en
High-throughput genotyping in ...... e-3-kinase and BRAF mutations.
@nl
prefLabel
High-throughput genotyping in ...... e-3-kinase and BRAF mutations.
@ast
High-throughput genotyping in ...... e-3-kinase and BRAF mutations.
@en
High-throughput genotyping in ...... e-3-kinase and BRAF mutations.
@nl
P2093
P2860
P1433
P1476
High-throughput genotyping in ...... e-3-kinase and BRAF mutations.
@en
P2093
Chi Hoon Maeng
Emanuele Palescandolo
Ha Young Park
Jeeyun Lee
Jiryeon Jang
Kyoung-Mee Kim
Laura MacConaill
Paul van Hummelen
Se Hoon Park
So Young Kang
P2860
P304
P356
10.1371/JOURNAL.PONE.0041655
P407
P577
2012-08-03T00:00:00Z